Sharenet Sites 
Sharenet Sites
Dealings in securities by directors, prescribed officers, the company secretary and the JSE LTIS 2018 Trust
JSE LIMITED
(Incorporated in the Republic of South Africa)
Registration number: 2005/022939/06
Share Code: JSE
ISIN Code: ZAE000079711
LEI: 213800MZ1VUQEBWRFO39
("JSE")
DEALINGS IN SECURITIES BY DIRECTORS, PRESCRIBED OFFICERS, THE COMPANY
SECRETARY AND THE JSE LTIS 2018 TRUST
The JSE LTIS 2018 Trust ("Trust") has acquired 494 170 JSE ordinary shares
in the open market on behalf of executive directors, members of the
executive committee, the Company Secretary and senior members of staff
("LTIS 2018 participants") to fulfil share awards granted in March 2020 to
these staff under the JSE’s Long-Term Incentive Scheme ("LTIS 2018").
These ordinary shares are held in trust and are restricted until all vesting
criteria are fulfilled whereupon the shares vest. To the extent that the
vesting criteria are not fulfilled the share awards are forfeited.
The vesting of these restricted JSE ordinary shares is subject to –
(i) the JSE achieving specified corporate performance targets over the
measurement period; and
(ii) a LTIS 2018 participant remaining in the employ of the JSE for the
vesting term (collectively "the vesting criteria").
These JSE ordinary shares were acquired on-market, with prior clearance,
at a volume-weighted average price of R102.7343 per ordinary share. The
total transaction value amounted to R50 768 209.03. The daily high, low
and volume-weighted average for the various transactions were –
Dates in 2020 Daily VWAP of
that JSE Number of JSE JSE shares Daily high Daily low
ordinary ordinary acquired price paid price paid
shares shares (cents per (cents per (cents per
acquired acquired share) share) share)
11 March 20 040 10389.56 10523 10290
12 March 182 066 10215.35 10322 9900
13 March 216 818 10524.00 10838 10059
16 March 75 246 9661.02 10235 9291
The requisite approvals have been granted by shareholders at the JSE’s
annual general meeting, in respect of the acquisition of JSE ordinary shares
in the open market and in respect of specific financial assistance to the
Trust for the purpose of acquiring these shares.
ACCEPTANCE OF ALLOCATIONS OF SECURITIES TO DIRECTORS, THE COMPANY SECRETARY
AND PRESCRIBED OFFICERS
Following the acquisition of the JSE ordinary shares by the Trust as
disclosed above, the executive directors, members of the executive committee
and the Company Secretary have on 13 March 2020 accepted grants of
restricted JSE ordinary shares, as reflected in this announcement.
Total number
of restricted Total Rand value
JSE ordinary of restricted JSE
shares ordinary shares
awarded and awarded and Nature of
Executive Role accepted accepted interest
Group CEO &
Executive Direct
L Fourie Director 84 570 8 688 240 beneficial
CFO & Executive Direct
A Takoordeen Director 24 916 2 559 728 beneficial
Prescribed Direct
A Greenwood Officer 26 506 2 723 075 beneficial
Prescribed Direct
D Khumalo Officer 19 668 2 020 578 beneficial
Prescribed Direct
H Kotze Officer 22 962 2 358 985 beneficial
Prescribed Direct
Z Morrison Officer 16 060 1 649 913 beneficial
Prescribed Direct
M Randall Officer 20 754 2 132 148 beneficial
Prescribed Direct
V Reddy Officer 23 918 2 457 199 beneficial
Group Company Direct
GA Brookes Secretary 11 794 1 211 648 beneficial
The restricted shares will vest in two tranches, one-half on 1 March 2023
and the remaining half on 1 March 2024, subject to the vesting criteria as
set out above being met.
The individual allocations (grant and acceptance) were approved by the JSE’s
Group Human Resources Committee and clearance to deal was granted by the
Chairman of the Board.
Sandton
17 March 2020
Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)
Date: 17-03-2020 05:24:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
